Literature DB >> 27144628

Centrally Mediated Disorders of Gastrointestinal Pain.

Laurie Keefer1, Douglas A Drossman2, Elspeth Guthrie3, Magnus Simrén4, Kirsten Tillisch5, Kevin Olden6, Peter J Whorwell7.   

Abstract

Centrally Mediated Abdominal Pain Syndrome (CAPS), formerly known as Functional Abdominal Pain Syndrome, can be distinguished from other functional GI disorders by its strong central component and relative independence from motility disturbances. CAPS is a result of central sensitization with disinhibition of pain signals rather than increased peripheral afferent excitability. A newly described condition, Narcotic Bowel Syndrome (NBS)/Opioid-Induced GI Hyperalgesia, is characterized by the paradoxical development of or increases in abdominal pain associated with continuous or increasing dosages of opioids. Patients only have relief when opioids are withdrawn. We define both conditions in the context of epidemiology, pathophysiology, clinical evaluation and treatment, emphasizing the importance of a physician-patient relationship in all aspects of care.
Copyright © 2016 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Centrally Mediated pain; Rome IV; chronic abdominal pain; functional abdominal pain; narcotic bowel

Year:  2016        PMID: 27144628     DOI: 10.1053/j.gastro.2016.02.034

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  9 in total

1.  British Society of Gastroenterology guidelines on the management of functional dyspepsia.

Authors:  Christopher J Black; Peter A Paine; Anurag Agrawal; Imran Aziz; Maria P Eugenicos; Lesley A Houghton; Pali Hungin; Ross Overshott; Dipesh H Vasant; Sheryl Rudd; Richard C Winning; Maura Corsetti; Alexander C Ford
Journal:  Gut       Date:  2022-07-07       Impact factor: 31.793

2.  Functional Abdominal Cramping Pain: Expert Practical Guidance.

Authors:  Stefan Müller-Lissner; Viola Andresen; Maura Corsetti; Luis Bustos Fernández; Sylvie Forestier; Fabio Pace; Miguel A Valdovinos
Journal:  J Clin Gastroenterol       Date:  2022-09-23       Impact factor: 3.174

3.  Validation of the Short-Form Esophageal Hypervigilance and Anxiety Scale.

Authors:  Tiffany H Taft; Livia Guadagnoli; Dustin A Carlson; Walter Kou; Laurie Keefer; John Pandolfino
Journal:  Clin Gastroenterol Hepatol       Date:  2021-01-14       Impact factor: 11.382

Review 4.  Chronic Pain in Children and Adolescents: Diagnosis and Treatment of Primary Pain Disorders in Head, Abdomen, Muscles and Joints.

Authors:  Stefan J Friedrichsdorf; James Giordano; Kavita Desai Dakoji; Andrew Warmuth; Cyndee Daughtry; Craig A Schulz
Journal:  Children (Basel)       Date:  2016-12-10

Review 5.  What Is New in Rome IV.

Authors:  Max J Schmulson; Douglas A Drossman
Journal:  J Neurogastroenterol Motil       Date:  2017-04-30       Impact factor: 4.924

Review 6.  Psychotropics, Antidepressants, and Visceral Analgesics in Functional Gastrointestinal Disorders.

Authors:  Hans Törnblom; Douglas A Drossman
Journal:  Curr Gastroenterol Rep       Date:  2018-11-05

7.  Pancreatic QST Differentiates Chronic Pancreatitis Patients into Distinct Pain Phenotypes Independent of Psychiatric Comorbidities.

Authors:  Mahya Faghih; Anna E Phillips; Louise Kuhlmann; Elham Afghani; Asbjørn M Drewes; Dhiraj Yadav; Vikesh K Singh; Søren S Olesen
Journal:  Clin Gastroenterol Hepatol       Date:  2020-10-22       Impact factor: 11.382

8.  Surgery for chronic pancreatitis in Finland is rare but seems to produce good long-term results.

Authors:  Mikael Parhiala; Juhani Sand; Johanna Laukkarinen
Journal:  World J Clin Cases       Date:  2021-12-16       Impact factor: 1.337

9.  Evaluation of the short-term efficacy of local analgesic (lidocaine) and opioid analgesic (sufentanil) on patients with centrally mediated abdominal pain syndrome: a randomized controlled trial.

Authors:  Hang Yang; Honglin Chen; Bing Hu
Journal:  Therap Adv Gastroenterol       Date:  2021-06-24       Impact factor: 4.409

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.